ARTICLE | Company News
Aphton cancer news
May 29, 2006 7:00 AM UTC
APHT filed for Chapter 11 bankruptcy. The company discontinued lead compound Insegia (G17DT) last May after it missed the primary endpoint of overall survival in a Phase III trial to treat pancreatic ...